Zogenix (ZGNX) Zohydro ER Fails to Win FDA Panel Backing
Zogenix (Nasdaq: ZGNX) Zohydro ER fails to win FDA panel backing.
You May Also Be Interested In
- Galmed Pharma (GLMD) IND Cleared by FDA: Submits App for Aramchol Fast Track Designation
- Alco Stores (ALCS) Issues Commentary on CAS Proxy
- Roth Capital Raises PT on Galena (GALE) to $8 Following Zuplenz Licensing News
Create E-mail Alert Related CategoriesCorporate News, FDA, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!